CA75557/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1999	3
2002	3
2003	1
2004	1
2005	4
2006	3
2007	4
2008	2
2009	5
2010	4
2011	2
2012	1
2024	0

1

Lakka SS, Gondi CS, Rao JS. Lakka SS, et al. Brain Pathol. 2005 Oct;15(4):327-41. doi: 10.1111/j.1750-3639.2005.tb00118.x. Brain Pathol. 2005. PMID: 16389945 Free PMC article. Review.

2

Antiangiogenic therapy in brain tumors.

Lakka SS, Rao JS. Lakka SS, et al. Expert Rev Neurother. 2008 Oct;8(10):1457-73. doi: 10.1586/14737175.8.10.1457. Expert Rev Neurother. 2008. PMID: 18928341 Free PMC article. Review.

3

Concepts in in vivo siRNA delivery for cancer therapy.

Gondi CS, Rao JS. Gondi CS, et al. J Cell Physiol. 2009 Aug;220(2):285-91. doi: 10.1002/jcp.21790. J Cell Physiol. 2009. PMID: 19391103 Free PMC article. Review.

4

Matrix metalloproteinases and their biological function in human gliomas.

Chintala SK, Tonn JC, Rao JS. Chintala SK, et al. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):495-502. doi: 10.1016/s0736-5748(99)00010-6. Int J Dev Neurosci. 1999. PMID: 10571411 Review.

5

Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.

Malla R, Gopinath S, Alapati K, Gondi CS, Gujrati M, Dinh DH, Mohanam S, Rao JS. Malla R, et al. PLoS One. 2010 Oct 29;5(10):e13731. doi: 10.1371/journal.pone.0013731. PLoS One. 2010. Retraction in: PLoS One. 2020 Jan 29;15(1):e0228688. doi: 10.1371/journal.pone.0228688 PMID: 21060833 Free PMC article. Retracted.

6

Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.

Raghu H, Gondi CS, Dinh DH, Gujrati M, Rao JS. Raghu H, et al. Mol Cancer. 2011 Oct 17;10:130. doi: 10.1186/1476-4598-10-130. Mol Cancer. 2011. PMID: 22004682 Free PMC article.

7

uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells.

Raghu H, Nalla AK, Gondi CS, Gujrati M, Dinh DH, Rao JS. Raghu H, et al. Mol Oncol. 2012 Feb;6(1):33-47. doi: 10.1016/j.molonc.2011.11.008. Epub 2011 Nov 30. Mol Oncol. 2012. PMID: 22177802 Free PMC article.

8

Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion.

Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP, Rao JS. Lakka SS, et al. Oncogene. 2002 Nov 14;21(52):8011-9. doi: 10.1038/sj.onc.1205894. Oncogene. 2002. PMID: 12439751

9

Doxorubicin-mediated apoptosis in glioma cells requires NFAT3.

Gopinath S, Vanamala SK, Gujrati M, Klopfenstein JD, Dinh DH, Rao JS. Gopinath S, et al. Cell Mol Life Sci. 2009 Dec;66(24):3967-78. doi: 10.1007/s00018-009-0157-5. Epub 2009 Sep 27. Cell Mol Life Sci. 2009. PMID: 19784808 Free PMC article.

10

Adenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth.

Mohan PM, Chintala SK, Mohanam S, Gladson CL, Kim ES, Gokaslan ZL, Lakka SS, Roth JA, Fang B, Sawaya R, Kyritsis AP, Rao JS. Mohan PM, et al. Cancer Res. 1999 Jul 15;59(14):3369-73. Cancer Res. 1999. PMID: 10416596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year